SS Innovations International Inc. (NASDAQ: SSII) announced that it will showcase its SSi Mantra surgical robotic system at the Society of Robotic Surgery (SRS) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The event, one of the largest gatherings of robotic surgery specialists, will feature a live kidney telesurgery broadcast from India, demonstrating the remote capabilities of the SSi Mantra platform.
Chairman and CEO Dr. Sudhir Srivastava will participate in multiple conference presentations covering telesurgery, robotic surgery adoption, and regulatory developments. The company's presence at SRS 2026 underscores its expanding global clinical footprint and growing focus on remote surgical capabilities.
As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric, and telesurgical procedures. Approximately 2,100 physicians have been trained on the platform, which has been utilized across more than 170 different surgical procedures. These milestones highlight the system's versatility and growing adoption in the medical community.
For more information about the SRS 2026 Annual Meeting, visit https://ibn.fm/FkgsY. To stay updated on the latest news and developments from SS Innovations, visit the company's newsroom at https://ibn.fm/SSII.
The SSi Mantra system represents a significant advancement in surgical robotics, offering a cost-effective and versatile alternative to existing platforms. Its telesurgery capabilities are particularly noteworthy, as they enable expert surgeons to perform procedures remotely, potentially expanding access to specialized surgical care in underserved regions.
The company's participation in SRS 2026 provides a platform to demonstrate the system's capabilities to a global audience of surgeons, researchers, and industry leaders. The live telesurgery broadcast is expected to be a highlight of the conference, showcasing the reliability and precision of the SSi Mantra in real-time remote operations.
With over 12,000 procedures completed and thousands of physicians trained, SS Innovations is positioning itself as a key player in the rapidly evolving field of robotic surgery. The expansion of its clinical footprint and the increasing adoption of its system suggest a growing demand for accessible and advanced surgical technologies.
The implications of this announcement extend beyond the company's commercial success. The successful integration of telesurgery into routine clinical practice could transform the way surgical care is delivered, particularly in remote and rural areas where access to specialist surgeons is limited. By demonstrating the SSi Mantra's capabilities at a major international conference, SS Innovations is contributing to the broader dialogue on the future of surgery and the role of robotics in improving patient outcomes.
